Type-1 Hepatorenal Syndrome Associated With Infections in Cirrhosis: Natural History, Outcome of Kidney Function, and Survival

被引:75
作者
Barreto, Rogelio [1 ,2 ,3 ,4 ]
Fagundes, Claudia [1 ,2 ,3 ,4 ]
Guevara, Monica [1 ,2 ,3 ,4 ]
Sola, Elsa [1 ,2 ,3 ,4 ]
Pereira, Gustavo [1 ,2 ,3 ,4 ]
Rodriguez, Ezequiel [1 ,2 ,3 ,4 ]
Graupera, Isabel [1 ,2 ,3 ,4 ]
Martin-Llahi, Marta [1 ,2 ,3 ,4 ]
Ariza, Xavier [1 ,2 ,3 ,4 ]
Cardenas, Andres [2 ,3 ,4 ,5 ]
Fernandez, Javier [1 ,2 ,3 ]
Rodes, Juan [2 ]
Arroyo, Vicente [1 ,2 ,3 ]
Gines, Pere [1 ,2 ,3 ,4 ]
机构
[1] Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Catalunya, Spain
[2] Inst Invest Biomed August Pi Sunyer IDI BAPS, Barcelona, Spain
[3] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
[4] Inst Reina Sofia Invest Nefrol, Barcelona, Spain
[5] Hosp Clin Barcelona, Gastroenterol Unit, E-08036 Barcelona, Spain
关键词
SPONTANEOUS BACTERIAL PERITONITIS; TERLIPRESSIN PLUS ALBUMIN; RENAL-FAILURE; SERUM CREATININE; MANAGEMENT; PREDICTORS; DIAGNOSIS; THERAPY;
D O I
10.1002/hep.26687
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Type-1 hepatorenal syndrome (HRS) is a common complication of bacterial infections in cirrhosis, but its natural history remains undefined. To assess the outcome of kidney function and survival of patients with type-1 HRS associated with infections, 70 patients diagnosed during a 6-year period were evaluated prospectively. Main outcomes were no reversibility of type-1 HRS during treatment of the infection and 3-month survival. Forty-seven (67%) of the 70 patients had no reversibility of type-1 HRS during treatment of the infection. [Correction to previous sentence added March 10, 2014, after first online publication: "Twenty-three (33%)" was changed to "Forty-;seven (67%)."] The main predictive factor of no reversibility of type-1 HRS was absence of infection resolution (no reversibility: 96% versus 48% in patients without and with resolution of the infection; P < 0.001). Independent predictive factors of no reversibility of type-1 HRS were age, high baseline serum bilirubin, nosocomial infection, and reduction in serum creatinine <0.3 mg/dL at day 3 of antibiotic treatment. No reversibility was also associated with severity of circulatory dysfunction, as indicated by more marked activity of the vasoconstrictor systems. In the whole series, 3-month probability of survival was only 21%. Factors associated with poor prognosis were baseline serum bilirubin, no reversibility of type-1 HRS, lack of resolution of the infection, and development of septic shock after diagnosis of type-1 HRS. Conclusion: Type-1 HRS associated with infections is not reversible in two-thirds of patients with treatment of infection only. No reversibility of type-1 HRS is associated with lack of resolution of the infection, age, high bilirubin, and no early improvement of kidney function and implies a poor prognosis. These results may help advance the management of patients with type-1 HRS associated with infections. (Hepatology 2014;59:1505-1513)
引用
收藏
页码:1505 / 1513
页数:9
相关论文
共 27 条
[1]
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice [J].
Angeli, Paolo ;
Gines, Pere .
JOURNAL OF HEPATOLOGY, 2012, 57 (05) :1135-1140
[2]
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[3]
Pathogenesis and treatment of hepatorenal syndrome [J].
Arroyo, Vicente ;
Fernandez, Javier ;
Gines, Pere .
SEMINARS IN LIVER DISEASE, 2008, 28 (01) :81-95
[4]
Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience [J].
Bajaj, Jasmohan S. ;
O'Leary, Jacqueline G. ;
Reddy, K. Rajender ;
Wong, Florence ;
Olson, Jody C. ;
Subramanian, Ram M. ;
Brown, Geri ;
Noble, Nicole A. ;
Thacker, Leroy R. ;
Kamath, Patrick S. .
HEPATOLOGY, 2012, 56 (06) :2328-2335
[5]
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics [J].
Boyer, Thomas D. ;
Sanyal, Arun J. ;
Garcia-Tsao, Guadalupe ;
Blei, Andres ;
Carl, Daniel ;
Bexon, Alice S. ;
Teuber, Peter .
JOURNAL OF HEPATOLOGY, 2011, 55 (02) :315-321
[6]
Management of complications of cirrhosis in patients awaiting liver transplantation [J].
Cardenas, A ;
Ginès, P .
JOURNAL OF HEPATOLOGY, 2005, 42 :S124-S133
[7]
Cardiovascular management of septic shock [J].
Dellinger, RP .
CRITICAL CARE MEDICINE, 2003, 31 (03) :946-955
[8]
Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis [J].
Fagundes, Claudia ;
Gines, Pere .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (06) :874-885
[9]
Renal failure and bacterial infections in patients with cirrhosis:: Epidemiology and clinical features [J].
Fasolato, Silvano ;
Angeli, Paolo ;
Dallagnese, Lucia ;
Maresio, Giulio ;
Zola, Erika ;
Mazza, Elena ;
Salinas, Freddy ;
Dona, Silvio ;
Fagiuoli, Stefano ;
Sticca, Antonietta ;
Zanus, Giacomo ;
Cillo, Umberto ;
Frasson, Ilaria ;
Destro, Carla ;
Gatta, Angelo .
HEPATOLOGY, 2007, 45 (01) :223-229
[10]
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study [J].
Fernandez, Javier ;
Acevedo, Juan ;
Castro, Miriam ;
Garcia, Orlando ;
Rodriguez de Lope, Carlos ;
Roca, Daria ;
Pavesi, Marco ;
Sola, Elsa ;
Moreira, Leticia ;
Silva, Anibal ;
Seva-Pereira, Tiago ;
Corradi, Francesco ;
Mensa, Jose ;
Gines, Pere ;
Arroyo, Vicente .
HEPATOLOGY, 2012, 55 (05) :1551-1561